Amedisys, Inc. (AMED) Forms $55.59 Double Bottom; Bob Evans Farms (BOBE) Sentiment Is 1.08

January 21, 2018 - By rebbecca

Bob Evans Farms, Inc. produces and distributes food products for grocery retailers in the United States. The company has market cap of $1.54 billion. The companyÂ’s products include refrigerated and frozen food items, including mashed potatoes, diced and shredded breakfast potatoes, Homestyle broccoli and cheese, seasoned Homestyle stuffing, six cheese pasta and sliced glazed apples, sausages, egg and cheese biscuits, sausage biscuits, egg and cheese croissant, breakfast burritos, breakfast bowls and kolaches, and soups, as well as sausage gravies; and fresh, smoked, and fully cooked pork and turkey sausage, ham, and hickory-smoked bacon products, as well as its oven bake scalloped potatoes, oven bake macaroni and cheese, oven bake double cheddar pasta with applewood smoked bacon, and oven bake southwest products. It has a 12.32 P/E ratio. It provides its home-style refrigerated side-dishes, pork sausage products, and various related frozen food items under the Bob Evans, Owens, Country Creek, and Pineland Farms brands, as well as its retail customers' private-label brands.

Amedisys, Inc. (AMED) formed double bottom with $53.37 target or 4.00% below today’s $55.59 share price. Amedisys, Inc. (AMED) has $1.89 billion valuation. The stock increased 1.46% or $0.8 during the last trading session, reaching $55.59. About 161,189 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 15.02% since January 21, 2017 and is uptrending. It has underperformed by 1.68% the S&P500.

Managed Asset Portfolios Llc holds 8.53% of its portfolio in Bob Evans Farms, Inc. for 353,467 shares. Foundation Asset Management Lp owns 190,181 shares or 4.59% of their US portfolio. Moreover, Koch Industries Inc has 1.33% invested in the company for 72,000 shares. The Jersey-based Brevan Howard Capital Management Lp has invested 1.23% in the stock. Pacific Global Investment Management Co, a California-based fund reported 69,477 shares.

It closed at $77.01 lastly. It is down 55.35% since January 21, 2017 and is uptrending. It has outperformed by 38.65% the S&P500.

Analysts await Bob Evans Farms, Inc. (NASDAQ:BOBE) to report earnings on March, 14. They expect $0.82 EPS, up 9.33% or $0.07 from last year’s $0.75 per share. BOBE’s profit will be $16.44 million for 23.48 P/E if the $0.82 EPS becomes a reality. After $0.35 actual EPS reported by Bob Evans Farms, Inc. for the previous quarter, Wall Street now forecasts 134.29% EPS growth.

Among 14 analysts covering Amedisys Inc. (NASDAQ:AMED), 6 have Buy rating, 0 Sell and 8 Hold. Therefore 43% are positive. Amedisys Inc. has $68.0 highest and $39 lowest target. $58.73’s average target is 5.65% above currents $55.59 stock price. Amedisys Inc. had 36 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Buy” rating by Oppenheimer on Thursday, July 27. The firm earned “Hold” rating on Monday, June 5 by RBC Capital Markets. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Hold” rating by RBC Capital Markets on Sunday, October 22. The stock of Amedisys, Inc. (NASDAQ:AMED) has “Hold” rating given on Monday, July 10 by RBC Capital Markets. Craig Hallum maintained Amedisys, Inc. (NASDAQ:AMED) rating on Thursday, November 9. Craig Hallum has “Buy” rating and $68.0 target. Mizuho maintained it with “Buy” rating and $65.0 target in Wednesday, November 8 report. The stock has “Outperform” rating by Oppenheimer on Monday, February 8. The firm earned “Mkt Perform” rating on Monday, January 11 by Raymond James. The stock of Amedisys, Inc. (NASDAQ:AMED) has “Buy” rating given on Monday, October 9 by SunTrust. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, May 6.

Since August 8, 2017, it had 0 insider buys, and 1 sale for $50,000 activity. $50,000 worth of Amedisys, Inc. (NASDAQ:AMED) shares were sold by Pearce David B..